Efficacy, Safety and Cost of Remote Monitoring of Patients With Cardiac Resynchronization Therapy (ECOST-CRT)
Efficacy, Safety and Cost of Comprehensive Versus Standard Remote Monitoring of Patients With Cardiac Resynchronization Therapy
Sponsor: Biotronik France
A NA clinical study on Cardiac Resynchronization Therapy and Heart Failure, this trial is completed. The trial is conducted by Biotronik France and has accumulated 10 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
10 versions recorded-
Feb 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Feb 2026 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2022 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2021 — Nov 2022 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
Jul 2019 — Sep 2020 [monthly]
Recruiting NA
-
Jun 2018 — Jul 2019 [monthly]
Recruiting NA
-
Sep 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Sep 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Biotronik France
- University Hospital, Lille
For direct contact, visit the study record on ClinicalTrials.gov .